 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-10631 |
943138-65-6 |
1H-Imidazole-4-ylboronic acid |
|
| AS-6770 |
131685-53-5 |
(R)-(-)-4-BENZYL-3-PROPIONYL-2-OXAZOLIDINONE |
|
| JR6-L1637 |
1335229-03-2 |
Borate(1-), [2-[(hydroxy-O)methyl]-2-methyl-1,3-propanediolato(3-)-O1,O3](1-methyl-1H-pyrazol-4-yl)-, sodium (1:1), (T-4)- |
|
| JR6-L1731 |
53041-12-6 |
Benzene, 1-[(1E)-3-bromo-1-propen-1-yl]-4-fluoro- |
|
| JR6-L2270 |
1185530-03-3 |
Glycinamide, 3-methyl-L-valyl- |
|
| JR6-L2282 |
1185897-76-0 |
Butanamide, 2-amino-3,3-dimethyl-N-(2-phenylethyl)-, (2S)- |
|
| JR6-L2288 |
672284-89-8 |
L-Glutamine, 3-methyl-L-valyl- (9CI) |
|
| JR6-L2290 |
908259-71-2 |
Butanamide, 2-amino-N-cycloheptyl-3,3-dimethyl-, (2S)- |
|
| JR6-L2292 |
171764-07-1 |
Butanamide, 2-amino-3,3-dimethyl-N-2-pyridinyl-, (2S)- |
|
| JR6-L2306 |
1185897-89-5 |
Butanamide, 2-amino-N-[(3-methoxyphenyl)methyl]-3,3-dimethyl-, (2S)- |
|
| JR6-L2640 |
91420-74-5 |
Oxirane, 2-(phenylmethyl)-, (2R)- |
|
| JR6-L2835 |
1192313-38-4 |
1H-Pyrazole-3-carboxylic acid, 5-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethoxy]-, ethyl ester |
|
| JR6-L3028 |
92972-48-0 |
5-Thiazolecarboxaldehyde, 2,4-dichloro- |
|
| JR6-L3042 |
|
(R)-1-(2,5-difluorophenyl)propan-2-ol |
|
| JR6-L3170 |
321901-15-9 |
[1,1'-Binaphthalene]-3-carboxylic acid, 2'-hydroxy-2-methoxy-, methyl ester |
|
| JR6-L3248 |
947337-17-9 |
[1,1'-Binaphthalene]-2,2'-diamine, 6,6'-dibromo-, (1S)- |
|
| JR6-L3328 |
147053-25-6 |
[1,1'-Binaphthalene]-2,2'-diol, 6-bromo-, (1R)- |
|
| JR6-L3881 |
1201196-84-0 |
Pyrrolidine, 2-[bis(3-fluorophenyl)[(trimethylsilyl)oxy]methyl]-, (2S)- |
|
| JR6-L3893 |
891482-18-1 |
2-Pyrrolidinemethanol, a,a-bis[4-(phenylmethoxy)phenyl]-, (2S)- |
|
| JR6-L4028 |
1947-62-2 |
1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, (2R,3R)- |
|
| JR6-L4084 |
916513-92-3 |
Benzenebutanoic acid, ß-amino-3,4-dimethoxy-, (ßS)- |
|
| JR6-L4096 |
270062-96-9 |
Benzenebutanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-4-methyl-, (ßS)- |
|
| JR6-L4318 |
1392015-46-1 |
Hexadecanoic acid, 16-sulfo-, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
|
| JR6-L4320 |
109545-77-9 |
17,26-Dithia-20,23-diazaheptacosanoic acid, 19,24-dioxo-27,27,27-triphenyl- |
|
| JR6-L4484 |
1204427-49-5 |
Methanone, [(3S)-3-hydroxy-1-pyrrolidinyl](3-methoxyphenyl)- |
|
| JR6-L4863 |
74205-22-4 |
Cyclobutanecarbonitrile, 1-[4-(1-methylethoxy)phenyl]- |
|
| JR6-L5104 |
622798-99-6 |
Acetamide, N-[4-[[(2-methoxyphenyl)(2-methyl-1H-indol-3-yl)methyl]amino]phenyl]- |
|
| JR6-L5415 |
1045814-68-3 |
Benzeneethanamine, a-ethenyl-2-iodo-3-methoxy-, (aS)- |
|
| JR6-L6289 |
181131-55-5 |
Benzamide, N-[5-[(11,12-dihydrodibenz[b,f]azocin-5(6H)-yl)carbonyl]-2-pyridinyl]-5-fluoro-2-methyl- |
|
| JR6-L6328 |
1350811-69-6 |
Hexanamide, N-[3-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-3-oxopropyl]-6-[[(4-methylphenyl)sulfonyl]oxy]- |
|
| JR6-L6352 |
1425107-87-4 |
Benzamide, 2-(hydroxyamino)-4-[[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]carbonyl]-6-nitro- |
|
| JR6-L7174 |
1088118-97-1 |
2,1,3-Benzothiadiazole, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
|
| JR6-L7186 |
1051368-76-3 |
2-(4-Fluoro phenoxy)-propylamine hydrochloride |
|
| JR6-L7196 |
|
Pra-Ala-Ala-Tyr-Leu-Gln-Glu-Thr-Gly-Lys-Pro-Leu-Asp-Glu-Thr-Leu-Lys(TAMRA) |
|
| JR6-L7478 |
1335683-91-4 |
3-Pyridineethanamine, 6-fluoro-a-methyl-, (aR)- |
|
| JR8-N0578 |
28649-60-7 |
Epoxylathyrol |
|
| JR8-N0590 |
481-49-2 |
Cepharanthine |
|
| JR8-N0763 |
26116-89-2 |
Rhodojaponin-II |
|
| JR8-N0782 |
2107-77-9 |
7,8-Dihydroxy-4-methylcoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|